Brüderlein Silke, Sommer Joshua B, Meltzer Paul S, Li Sufeng, Osada Takuya, Ng David, Möller Peter, Alcorta David A, Kelley Michael J
Institute of Pathology, Ulm University, D-89081 Ulm, Germany.
Sarcoma. 2010;2010:630129. doi: 10.1155/2010/630129. Epub 2010 Dec 30.
Immortal tumor cell lines are an important model system for cancer research, however, misidentification and cross-contamination of cell lines are a common problem. Seven chordoma cell lines are reported in the literature, but none has been characterized in detail. We analyzed gene expression patterns and genomic copy number variations in five putative chordoma cell lines (U-CH1, CCL3, CCL4, GB60, and CM319). We also created a new chordoma cell line, U-CH2, and provided genotypes for cell lines for identity confirmation. Our analyses revealed that CCL3, CCL4, and GB60 are not chordoma cell lines, and that CM319 is a cancer cell line possibly derived from chordoma, but lacking expression of key chordoma biomarkers. U-CH1 and U-CH2 both have gene expression profiles, copy number aberrations, and morphology consistent with chordoma tumors. These cell lines also harbor genetic changes, such as loss of p16, MTAP, or PTEN, that make them potentially useful models for studying mechanisms of chordoma pathogenesis and for evaluating targeted therapies.
永生肿瘤细胞系是癌症研究的重要模型系统,然而,细胞系的错误鉴定和交叉污染是一个常见问题。文献中报道了七种脊索瘤细胞系,但均未进行详细表征。我们分析了五个假定的脊索瘤细胞系(U-CH1、CCL3、CCL4、GB60和CM319)的基因表达模式和基因组拷贝数变异。我们还创建了一个新的脊索瘤细胞系U-CH2,并提供了细胞系的基因型以进行身份确认。我们的分析表明,CCL3、CCL4和GB60不是脊索瘤细胞系,而CM319是一个可能源自脊索瘤的癌细胞系,但缺乏关键脊索瘤生物标志物的表达。U-CH1和U-CH2都具有与脊索瘤肿瘤一致的基因表达谱、拷贝数畸变和形态。这些细胞系还存在遗传变化,如p16、MTAP或PTEN的缺失,这使得它们成为研究脊索瘤发病机制和评估靶向治疗的潜在有用模型。